We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
By clicking "Allow All" you agree to the storing of cookies on your device to enhance site navigation, analyse site usage and support us in providing free open access scientific content. More info.
Researchers worldwide in the fields of CRISPR gene editing, oncology, stem cell biology, immunology and neurobiology use Cell Microsystems products, advancing sophisticated discovery across the life sciences.
The company’s CellRaft AIR® System addresses two widespread challenges facing scientists: the ability to actively select viable single cells or clonal colonies based on their phenotype, and match these cells to clonal expansion or molecular analyses. Cells are seeded, imaged, identified, and isolated on Cell Microsystem’s CellRaft® Arrays.
We have tested more than 100 Cell Lines with CellRaft Technology to demonstrate the high outgrowth efficiencies using our platform.
The company currently markets its products to researchers worldwide, and prides itself on being a customer-focused organization responsive to feedback and inspired to fuel deeper contributions to science.
Discover CellRaft Technology to Increase the Growth of Colonies and Organoids
Challenges and opportunities in monoclonal cell lines
How to accelerate the development of in vitro models of chemoresistance?
How to accelerate the generation of single-cell clones
How to accelerate the use of iPSCs in drug development
How to automate cloning for CRISPR workflows
How to make iPSC cloning more efficient?
Identifying rare double positive clones
Overcoming the challenges of limiting dilution
What platforms to develop clonal iPSC derived organoids?